FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

GLAXO Share Price Target

GlaxoSmithKline Pharmaceuticals Ltd.
NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Sector: Pharmaceuticals and health care

GLAXO Rating

3/5 (1 Ratings)
GLAXO Share Price *
1,341.35 -3.55 (-0.26%)
* (quote may be delayed)

1 GLAXO share price target reports by brokerages below. See what is analyst's view on GLAXO share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.


You can also find GLAXO share price target tomorrow or next week from GLAXO discussion forum.

GLAXO Share Price Forecast - Consensus
No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
1350.00
Consensus Potential
0.38%

GLAXO Share Price Target - Broker Reports - 2019

21-May-19
Price @ Call: 1263.7
Target: 1350
NEUTRAL
We maintain our estimates for FY20/21, factoring in moderate revenue growth on account of portfolio rationalization and the increased share of relatively high-margin products in the portfolio. We continue valuing GLXO at 43x 12M forward earnings to arrive at a target price of INR1,350 (prior: 1,309). While improved profitability may drive a 16% earnings CAGR over FY19-21, valuations provide limited upside from current levels. We, thus, maintain our Neutral rating on the stock.
... Read more

GLAXO Share Price Target - Broker Reports - 2018

23-Oct-18
Price @ Call: 1370.35
Target: 950
SELL

26-Jul-18
Price @ Call: 1578.95
Target: 950
SELL

25-May-18
Price @ Call: 1191.69
Target: 1250
NEUTRAL

2-Feb-18
Price @ Call: 1216.94
Target: 1550
BUY

3-Feb-18
Price @ Call: 1216.94
Target: 1250
NEUTRAL

GLAXO Share Price Target - Broker Reports - 2017

30-Oct-17
Price @ Call: 1269
Target: 762.5
SELL

GLAXO Share Price Target - Broker Reports - 2016

4-Nov-16
Price @ Call: 2738
Target: 1670
SELL

  • GLAXO - Share Price Target Potential

    keyboard_arrow_down
    BrokerageTargetPotential
    Motilal Oswal1,3500.38%
  • GLAXO Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,397.65
    Upside Target 21,379.85
    Upside Target 11,360.6
    Pivot1,342.8
    Downside Target 11,323.55
    Downside Target 21,305.75
    Downside Target 31,286.5
  • GLAXO Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,456.57
    Upside Target 21,410.08
    Upside Target 11,373.02
    Pivot1,326.53
    Downside Target 11,289.47
    Downside Target 21,242.98
    Downside Target 31,205.92
  • GLAXO Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,904.93
    Upside Target 21,826.47
    Upside Target 11,745.93
    Pivot1,667.47
    Downside Target 11,586.93
    Downside Target 21,508.47
    Downside Target 31,427.93
  • GLAXO Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,379.85
    Upside Target 21,365.7
    Upside Target 11,356.95
    Pivot1,342.8
    Downside Target 11,328.65
    Downside Target 21,319.9
    Downside Target 31,305.75
  • GLAXO Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,410.08
    Upside Target 21,378.17
    Upside Target 11,358.45
    Pivot1,326.53
    Downside Target 11,294.62
    Downside Target 21,274.9
    Downside Target 31,242.98
  • GLAXO Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,826.47
    Upside Target 21,765.73
    Upside Target 11,728.2
    Pivot1,667.47
    Downside Target 11,606.73
    Downside Target 21,569.2
    Downside Target 31,508.47
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.